Ramani Varanasi

Ramani is a Senior Biopharma Executive and Entrepreneur with over 25 years of biopharmaceutical industry experience. She is the Managing Director of ReVive Advisors, where she serves as a trusted partner to CEOs and Executive Management and advises on corporate strategy, fundraising, corporate development, and operations. She was a Co-founder and until recently served as the President and CEO of X-Biotix Therapeutics, a biopharma company focused on novel antibiotics to combat the ever-increasing global issue of multi-drug resistance caused by “Superbugs”.

Being attracted to mission-driven initiatives, Ramani has operated with an entrepreneurial vision and passion for launching, building and being part of successful organizations by integrating research and business strategies focused on innovative medicines and solutions having a global impact. Her strong sense of purpose and committed sense of urgency with a results-oriented attitude have been beacons that have supported her through the navigation of her career from a research scientist to her role as a President and CEO. She has held senior positions in Research and Business/Corporate Development including at Merck, Millennium (acquired by Takeda May 2008), Momenta (acquired by J&J Aug 2020), Archemix, and was a Co-Founder and Chief Business Officer at Checkmate Pharmaceuticals (IPO in Aug 2020).

Over the course of her career, she has been involved in the formation of value-driven strategic partnerships with companies and research organizations globally, including in emerging markets such as Asi… Read More